Back
VolitionRX Ltd. 10K Form
Sell
18
VNRX
VolitionRX Ltd.
Last Price:
$0.31
Seasonality Move:
8.86%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-02-20 | 10K | VNRX/VolitionRX Ltd. Annual |
| 2019-11-12 | 10Q | VNRX/VolitionRX Ltd. Quarterly |
| 2019-08-12 | 10Q | VNRX/VolitionRX Ltd. Quarterly |
| 2019-05-08 | 10Q | VNRX/VolitionRX Ltd. Quarterly |
| 2019-03-13 | 10K | VNRX/VolitionRX Ltd. Annual |
| 2018-11-07 | 10Q | VNRX/VolitionRX Ltd. Quarterly |
Receive VNRX News And Ratings
See the #1 stock for the next 7 days that we like better than VNRX
VNRX Financial Statistics
Sales & Book Value
| Annual Sales: | $1.2M |
|---|---|
| Cash Flow: | $-3.5M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.32 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -0.22740 |
|---|---|
| Net Income (TTM): | $-23.1M |
| Gross Margin: | $-68.7K |
| Return on Equity: | 0% |
| Return on Assets: | -251.98% |
VolitionRX Ltd. Earnings Forecast
Key VolitionRX Ltd. Financial Ratios
-
The Gross Profit Margin over the past 9 years for VNRX is -5.57%.
-
The Selling, General & Administrative Expenses for VNRX have been equal to 1,122.98% of Gross Profit Margin.
-
The Research & Development expenses have been 1,079.59% of Revenue.
-
The Net Earning history of VNRX is -2,209.81% of Total Revenues.
-
Per Share Earnings over the last 21 years have been positive in 10 years.
VolitionRX Ltd. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYAM |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | VNRX |
| CUSIP: | 928661 |
| Website: | volition.com |
Debt
| Debt-to-Equity Ratio: | -0.33 |
|---|---|
| Current Ratio: | 0.12 |
| Quick Ratio: | 0.04 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
VNRX Technical Analysis vs Fundamental Analysis
Sell
18
VolitionRX Ltd. (VNRX)
is a Sell
Is VolitionRX Ltd. a Buy or a Sell?
-
VolitionRX Ltd. stock is rated a SellThe current VolitionRX Ltd. [VNRX] share price is $0.28. The Score for VNRX is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.